Purchase Order 75N95021P00662

The National Institutes of Health's National Center for Advancing Translational Sciences awarded a $2.1 million firm fixed price purchase order to Avista Pharma Solutions, Inc., doing business as Cambrex, for the acquisition of two kilograms of cGMP-grade GS-441524 drug substance with an option for two additional kilograms. The drug substance will support preclinical and Phase I clinical studies by the NIH to evaluate GS-441524's potential as a COVID-19 treatment through assessing its safety,...

This is a federal contract awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services (HHS), to Asuragen Incorporated, a small business. The contract is for the development and supply of a BCR-ABL 1 RT-QPCR test to improve monitoring of chronic myeloid leukemia (CML). This is a Phase II Small Business Innovation Research (SBIR) contract with a ceiling value of $1,489,494.00. The contract is a definitive contract with a cost-plus-fixed-fee pricing...

This firm-fixed-price delivery order was awarded to Societal CDMO San Diego, LLC (a division of Recro Pharma, Inc.) by the National Cancer Institute, part of the National Institutes of Health at the Department of Health and Human Services. The $546,667.00 contract is for the production of an engineering batch, current Good Manufacturing Practice (cGMP) batch, delivery, and shelf-life study of ammonium tetrathiomolybdate (ATTM) capsules to support a clinical trial for a potential cancer...

This federal contract award, with an ID of SPE2DB20D1109|SPE2DB21FQ08Y, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4554860117 - CALQUENCE 100 MG CAPSULE 60S, a pharmaceutical product, with a ceiling value of $9,193.82. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition....

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $951,000 Delivery Order contract to Regimed Medical of O'Fallon, Missouri. Under the terms of the firm fixed price contract, Regimed Medical will provide 150 milligram capsules of Nilotinib in 120 blister packs and 200 milligram capsules of Nilotinib in 36 blister packs in support of the Division of Cancer Treatment and Diagnosis, Cancer Therapy Evaluation Program. The contract period of...

This federal contract award, with an ID of SPE2DB20D3101|SPE2DB22FH3C2, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $9,193.82 firm fixed-price delivery order is for the supply of the pharmaceutical product CALQUENCE 100 MG CAPSULE 60S. The contract is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $5,593.77 firm fixed-price contract is for the procurement of CALQUENCE 100 MG TABLET 60S, a medication used in the treatment of cancer. The contract is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...

This is a delivery order awarded to Regimed Medical, a minority-owned small disadvantaged business located in O'Fallon, Missouri, under a $6.34 million Indefinite Delivery Contract (IDC) with the National Institutes of Health (NIH) National Cancer Institute. The delivery order, valued at $219,850.00, is for the procurement of 200 mg nilotinib tablets to support the NIH's Division of Cancer Treatment and Diagnosis and Cancer Therapy Evaluation Program. This requirement is not set-aside and is...

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $1.7 million delivery order contract to Regimed Medical to procure 240 blister packs of 150 mg nilotinib tablets and 40 blister packs of 200 mg nilotinib tablets in support of the Division of Cancer Treatment and Diagnosis, Cancer Therapy Evaluation Program. The firm fixed price contract runs from November 17, 2023 through November 16, 2024 and will be performed in Frederick, Maryland.

This federal contract award is for the delivery of CALQUENCE 100 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. The contract has a ceiling value of $25,726.08 and is a Firm Fixed Price Delivery...